ZLAB logo

ZLAB Zai Lab Limited

NASDAQ Global Market · Biotechnology · Healthcare

$21.03
-0.89 (-4.06%)

Zai Lab Limited, established in 2013 and based in Shanghai, China, is a biopharmaceutical company dedicated to developing and bringing to market innovative medical treatments. Its core focus spans oncology, autoimmune diseases, infectious diseases, and neurological conditions, primarily serving patients in Mainland China and Hong Kong. The company's portfolio of commercialized products includes Ze…

Market Cap: $2.37Bwww.zailaboratory.com

Price

$23.32+12.39%
$16.48$18.76$21.04$23.32
Apr 29Aug 7

Social Signal Score

50
5d
—
30d
55
6 mentions
+0.0%
60d
47
10 mentions
+0.0%
90d
47
11 mentions
+0.0%
news: 11

Analyst Ratings

11 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 2Sell 0Strong Sell 0
Avg price target$35+66.4%
Low $35Median $35High $35
Current Consensus

Revenue

$108.21M
$0.00$42.53M$85.06M$127.60M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-1.76
$-2.04–$-1.57
6 analysts
FY2026
$-1.97
$-2.32–$-1.61
3 analysts
FY2027
$-1.90
$-2.39–$-1.41
6 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Ying Du
Sector
Healthcare
Industry
Biotechnology
Employees
1,784
Beta
0.83
Country
CN
Piotroski score
2 / 9 (Weak)
Altman Z-score
-0.39
www.zailaboratory.com